Pricing Log in Create free account

Neuraxis, Inc. (NRXS) vs Tonix Pharmaceuticals Holding Corp. (TNXP)

Neuraxis, Inc. and Tonix Pharmaceuticals Holding Corp. are both Biotechnology companies. Neuraxis, Inc. and Tonix Pharmaceuticals Holding Corp. are of similar size ($87.6M and $86.2M). Tonix Pharmaceuticals Holding Corp. grew revenue faster over the last twelve months: 196.0% against 65.2%. Neuraxis, Inc. has the higher net margin (−159.0% vs −548.6%) and the higher return on invested capital (0.00% vs −224.5%). Across the 16 metrics below, Neuraxis, Inc. leads on 8 and Tonix Pharmaceuticals Holding Corp. on 8.

Valuation

Metric NRXS TNXP Biotechnology median
P/E n/m n/m 10.26
P/S 13.79 2.65 9.18
P/B 10.89 0.35 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 0.56 0.65
EV/Sales 12.23 (3.15) 8.98
Earnings yield (12.89%) (278.89%) (34.89%)
Free cash flow yield (7.88%) (205.28%) (24.52%)

Profitability

Metric NRXS TNXP Biotechnology median
Gross margin 85.56% 83.83% 65.16%
Operating margin (144.51%) (568.43%) 0.00%
Net margin (159.01%) (548.64%) 0.00%
Free cash flow margin (106.10%) (543.29%) 0.00%
Return on equity (153.96%) (81.82%) (50.12%)
Return on assets (98.96%) (72.34%) (45.60%)
Return on invested capital 0.00% (224.52%) 0.00%

Growth

Metric NRXS TNXP Biotechnology median
Revenue growth (TTM) 65.22% 196.02% 6.26%
EPS growth (last fiscal year) 22.13% 91.75% 29.88%
Revenue growth, 5-year CAGR 13.08% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NRXS TNXP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.04 6.61 4.89
Net debt to EBITDA 0.64 1.68 1.01

Dividend

Metric NRXS TNXP Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric NRXS TNXP Biotechnology median
Market cap 86.15m 87.64m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack